锦波生物832982.BJ:功能蛋白小巨人,医疗+美容下游广阔
Property: NBS 4M24: REI continued weakening as expected; BJ’s relaxation showed noticeable effect
锦波生物(832982.BJ)2024年半年报点评:24Q2归母净利同比+213%,收入与利润增速表现亮眼
锦波生物(832982.BJ)2023年三季报点评:重组胶原蛋白产品带动收入与利润快速提升,公司未来看点充足
China Property SectorNBS Nov data in line, expect new policy in BJ/SH to boost secondary market in Dec
锦波生物(832982.BJ)2023年三季报点评
北 交12英寸认证推进及产能释放蓄势新一轮增长,并表凯德芯贝盈利短期承压 所 凯德石英(835179.BJ)研究北交所信息更新
锦波生物(832982.BJ)24H1点评:薇旖美延续亮眼增长,整体盈利能力显著提升
China Property Sector: NBS Nov data in line, expect new policy in BJ/SH to boost secondary market in Dec
AIPC浪潮下笔电产业链迎新机遇,募投扩产+海外布局齐发力 泓禧科技(871857.BJ)